Quantification in positron emission tomography for research in pharmacology and drug development
Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate a...
Gespeichert in:
Veröffentlicht in: | Nuclear medicine communications 2004-07, Vol.25 (7), p.643-646 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 646 |
---|---|
container_issue | 7 |
container_start_page | 643 |
container_title | Nuclear medicine communications |
container_volume | 25 |
creator | Cunningham, V.J Gunn, R.N Matthews, J.C |
description | Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation. |
doi_str_mv | 10.1097/01.mnm.0000134330.38536.bc |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66657310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66657310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</originalsourceid><addsrcrecordid>eNpFkM1u1TAQRr0A0VL6CihiwS6pJ5M4NjtUUUCqVCHB2nWc8U3aJA52QnXfHt8fqd7YMzrzjXUY-wS8AK6aGw7FNE8FTwewQuQFyhpF0do37JJDhTkKFBfsfYxPiZEomnfsAuqSy0qqS_b4azPzOrjBmnXwczbM2eLjsIb0pmmI8dBc_eR3wSz9PnM-ZIEimWD7I9ybMBnrR7_bZ2busi5su6yjfzT6ZaJ5_cDeOjNGuj7fV-zP3bfftz_y-4fvP2-_3ucWBcdctVVrwVYlOtWCMy01NbfSSkAuJQlVY1k35IwjqQSCRdVBB0IoUzplAK_Y51PuEvzfjeKq0-8tjaOZyW9RCyHqBoEn8MsJtMHHGMjpJQyTCXsNXB-cag46OdWvTvXRqW5tGv543rK1E3Wvo2ehCahOwIsfVwrxedxeKOiezLj2x0hRIuQl5xVvUpUfWoj_AfSlh9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66657310</pqid></control><display><type>article</type><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</creator><creatorcontrib>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</creatorcontrib><description>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</description><identifier>ISSN: 0143-3636</identifier><identifier>DOI: 10.1097/01.mnm.0000134330.38536.bc</identifier><identifier>PMID: 15208489</identifier><language>eng</language><publisher>England: Lippincott Williams & Wilkins, Inc</publisher><subject>Algorithms ; Animals ; Brain - blood supply ; Brain - diagnostic imaging ; Brain - metabolism ; Brain Mapping - methods ; Drug Design ; Fluorodeoxyglucose F18 - pharmacokinetics ; Humans ; Image Enhancement - methods ; Image Interpretation, Computer-Assisted - methods ; Pharmacology - methods ; Positron-Emission Tomography - methods ; Positron-Emission Tomography - trends ; Radiopharmaceuticals - pharmacokinetics ; Research Design ; Sensory Receptor Cells - metabolism</subject><ispartof>Nuclear medicine communications, 2004-07, Vol.25 (7), p.643-646</ispartof><rights>2004 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</citedby><cites>FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15208489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunningham, V.J</creatorcontrib><creatorcontrib>Gunn, R.N</creatorcontrib><creatorcontrib>Matthews, J.C</creatorcontrib><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><title>Nuclear medicine communications</title><addtitle>Nucl Med Commun</addtitle><description>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</description><subject>Algorithms</subject><subject>Animals</subject><subject>Brain - blood supply</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Brain Mapping - methods</subject><subject>Drug Design</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>Humans</subject><subject>Image Enhancement - methods</subject><subject>Image Interpretation, Computer-Assisted - methods</subject><subject>Pharmacology - methods</subject><subject>Positron-Emission Tomography - methods</subject><subject>Positron-Emission Tomography - trends</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Research Design</subject><subject>Sensory Receptor Cells - metabolism</subject><issn>0143-3636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1u1TAQRr0A0VL6CihiwS6pJ5M4NjtUUUCqVCHB2nWc8U3aJA52QnXfHt8fqd7YMzrzjXUY-wS8AK6aGw7FNE8FTwewQuQFyhpF0do37JJDhTkKFBfsfYxPiZEomnfsAuqSy0qqS_b4azPzOrjBmnXwczbM2eLjsIb0pmmI8dBc_eR3wSz9PnM-ZIEimWD7I9ybMBnrR7_bZ2busi5su6yjfzT6ZaJ5_cDeOjNGuj7fV-zP3bfftz_y-4fvP2-_3ucWBcdctVVrwVYlOtWCMy01NbfSSkAuJQlVY1k35IwjqQSCRdVBB0IoUzplAK_Y51PuEvzfjeKq0-8tjaOZyW9RCyHqBoEn8MsJtMHHGMjpJQyTCXsNXB-cag46OdWvTvXRqW5tGv543rK1E3Wvo2ehCahOwIsfVwrxedxeKOiezLj2x0hRIuQl5xVvUpUfWoj_AfSlh9M</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Cunningham, V.J</creator><creator>Gunn, R.N</creator><creator>Matthews, J.C</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Quantification in positron emission tomography for research in pharmacology and drug development</title><author>Cunningham, V.J ; Gunn, R.N ; Matthews, J.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3603-9b4bc1c423f9b1fabe750c8c813088e6953257efafe89631c39d1d1669a2f9a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Algorithms</topic><topic>Animals</topic><topic>Brain - blood supply</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Brain Mapping - methods</topic><topic>Drug Design</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>Humans</topic><topic>Image Enhancement - methods</topic><topic>Image Interpretation, Computer-Assisted - methods</topic><topic>Pharmacology - methods</topic><topic>Positron-Emission Tomography - methods</topic><topic>Positron-Emission Tomography - trends</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Research Design</topic><topic>Sensory Receptor Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunningham, V.J</creatorcontrib><creatorcontrib>Gunn, R.N</creatorcontrib><creatorcontrib>Matthews, J.C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunningham, V.J</au><au>Gunn, R.N</au><au>Matthews, J.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification in positron emission tomography for research in pharmacology and drug development</atitle><jtitle>Nuclear medicine communications</jtitle><addtitle>Nucl Med Commun</addtitle><date>2004-07</date><risdate>2004</risdate><volume>25</volume><issue>7</issue><spage>643</spage><epage>646</epage><pages>643-646</pages><issn>0143-3636</issn><abstract>Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation.</abstract><cop>England</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>15208489</pmid><doi>10.1097/01.mnm.0000134330.38536.bc</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0143-3636 |
ispartof | Nuclear medicine communications, 2004-07, Vol.25 (7), p.643-646 |
issn | 0143-3636 |
language | eng |
recordid | cdi_proquest_miscellaneous_66657310 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Algorithms Animals Brain - blood supply Brain - diagnostic imaging Brain - metabolism Brain Mapping - methods Drug Design Fluorodeoxyglucose F18 - pharmacokinetics Humans Image Enhancement - methods Image Interpretation, Computer-Assisted - methods Pharmacology - methods Positron-Emission Tomography - methods Positron-Emission Tomography - trends Radiopharmaceuticals - pharmacokinetics Research Design Sensory Receptor Cells - metabolism |
title | Quantification in positron emission tomography for research in pharmacology and drug development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20in%20positron%20emission%20tomography%20for%20research%20in%20pharmacology%20and%20drug%20development&rft.jtitle=Nuclear%20medicine%20communications&rft.au=Cunningham,%20V.J&rft.date=2004-07&rft.volume=25&rft.issue=7&rft.spage=643&rft.epage=646&rft.pages=643-646&rft.issn=0143-3636&rft_id=info:doi/10.1097/01.mnm.0000134330.38536.bc&rft_dat=%3Cproquest_cross%3E66657310%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66657310&rft_id=info:pmid/15208489&rfr_iscdi=true |